Application of duplex ultrasound imaging in determining in-stent stenosis during surveillance after mesenteric artery revascularization  by Baker, Aaron C. et al.
From the Western Vascular Society
Application of duplex ultrasound imaging in
determining in-stent stenosis during surveillance
after mesenteric artery revascularization
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David L. Dawson, MD,a William C. Pevec, MD,a and Nasim Hedayati, MD,a Sacramento and Davis, Calif
Objective: Currently, there are no well-established duplex ultrasound (DUS) criteria for the evaluation of the mesenteric
arteries after stenting for occlusive disease. Previous studies suggested DUS velocity criteria in the native superior
mesenteric artery (SMA) overestimate stenosis in stented arteries, but most studies have not evaluated DUS imaging after
SMA stenting longitudinally. This study was undertaken to determine the accuracy of DUS after mesenteric artery
revascularization and, in particular, to evaluate the utility of DUS imaging for the detection of in-stent stenosis (ISS) of
the SMA.
Methods:A retrospective record reviewwas performed for all patients who underwent SMA stenting for chronicmesenteric
ischemia at a single institution from January 2004 to May 2011.
Results:Mesenteric artery occlusive disease resulted in 24 patients undergoing mesenteric stenting of the SMA alone (n
20) or the SMA and celiac artery simultaneously (n  3). The mean  standard deviation peak systolic velocity (PSV) in
13 prestent DUS images of the SMA was 464 130 cm/s. Prestenting angiography revealed an average SMA stenosis of
79%  14%. After stenting, completion angiography in each case revealed <20% residual stenosis. No significant
correlation was identified between SMA PSV and angiographic stenosis before and after stenting (P > .05). Follow-up
SMA DUS imaging showed an average PSV of 335  138 cm/s at 0.9  1.5 months, 360  143 cm/s at 4.8 2.6
months, and 389  95 cm/s at 14.4  5.1 months. A significant difference existed between the prestent and the first
poststent mean SMA PSV (P < .05), but no significant difference existed between each poststenting interval. Eight
reinterventions for SMA ISS were performed, with a mean elevated in-stent SMA PSV of 505  74 vs 341  145 cm/s in
patientswhodid not undergo reintervention.Angiography before the eight reinterventions demonstrated an average SMAISS
of 53%  25%. In-stent SMA PSV decreased from 505  74 to 398  108 cm/s after the reintervention (P < .05).
Conclusions: Consistent with other reports, our data demonstrate the PSV in successfully stented SMAs remains higher
than the PSV threshold of 275 cm/s used for the diagnosis of high-grade native SMA stenosis. In addition, in-stent SMA
PSVs did not significantly change over DUS surveillance for patients who did not undergo reintervention. Thus,
obtaining a baseline DUS early after mesenteric stenting should be considered to compare future surveillance DUS. An
increase above this baseline or an in-stent SMA PSV approaching 500 cm/s should be considered suspicious for ISS, but
larger prospective studies will be required to validate these preliminary findings. ( J Vasc Surg 2012;56:1364-72.)
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aDuplex ultrasound (DUS) imaging is effective for iden-
tifying a significant visceral artery stenosis.1-5 Peak systolic
velocities (PSVs) of 275 cm/s in the superior mesenteric
artery (SMA) and 200 cm/s in the celiac artery (CA), or
the absence of flow, correlate with a 70% angiographic
stenosis.2,3 Bypass grafts or endarterectomy can be used for
surgical revascularization; however, endovascular treat-
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1364ent with stenting of the SMA and CA has emerged as a
ess invasive alternative.6-15 Stenting as a therapy for the
reatment of chronic mesenteric ischemia (CMI) is increas-
ngly being performed16; in fact, many institutions may
ow consider an endovascular approach to CMI as a first-
ine therapy.
Durability of visceral revascularization is of concern.
urveillance of mesenteric bypass grafts has long been
valuated with DUS imaging.17,18 However, specific sur-
eillance criteria for determining the severity of bypass graft
tenosis have not been validated. Further, no guidelines
re available to support decisions about the need for and
iming of reintervention after mesenteric artery stenting.
ecisions to re-treat have been guided, alone or in
ombination, by recurrence of symptoms and imaging
ndings, including results of computed tomography an-
iography (CTA), DUS imaging, and magnetic reso-
ance angiography (MRA).6-9,11,19
Mesenteric artery in-stent stenosis (ISS) is a clinically
ignificant issue. Although data indicate lower morbidity
nd mortality with stenting compared with surgical revas-
ularization, most report inferior patency rates with stents,
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Volume 56, Number 5 Baker et al 1365with more frequent repeat interventions, compared with
open procedures.6-9,11,15 Thus, clinical assessment and sur-
veillance imaging after visceral artery revascularization pro-
cedures remain critical components in patient follow-up.
Previous studies have demonstrated that the velocity
criteria established for the diagnosis of high-grade stenosis
of native SMA, renal, and carotid arteries overestimates the
severity of ISS, but no studies have reported the application
of DUS imaging in determining ISS of the stented mesen-
teric vessels over follow-up.20-24 This current study evalu-
ates DUS findings of stented mesenteric arteries over a
longer follow-up period than previously reported and at-
tempts to elucidate findings on surveillance DUS imaging
of patients who did not require reintervention compared
with those who did undergo reintervention to better define
potential criteria that can guide the need for and timing of
reintervention for mesenteric ISS.
METHODS
Approval for medical record review was obtained from the
Institutional Review Board at theUniversity of California Davis.
Patients. A retrospective review was performed for all
patients who underwent SMA stenting for CMI between
January 2004 and May 2011 at the University of California
Davis Health System. Indication for the intervention, pres-
ence of symptoms (postprandial abdominal pain, food fear,
weight loss, vomiting, and diarrhea) before and after interven-
tion, age, and sex were extracted from the medical records.
DUS assessments. Preprocedure and postprocedure
mesenteric DUS imaging performed at a vascular laboratory
accredited by the Intersocietal Commission for the Accredita-
tion of Vascular Laboratories were reviewed. The standard
surveillance protocol after mesenteric artery stenting involves
a DUS study initially at 1, 3, and 6 months, and then yearly
afterward. DUS assessments were performed on patients in a
fasted state and after having refrained from smoking. The
vessel of interest was interrogated at multiple points along the
length to determine the PSV. For the purpose of this study,
the PSVs of the SMA and CAs before and after stenting were
extracted after reviewing the records and DUS images. The
degree of angiographic stenosis of the SMA and CA before
and after intervention was initially extracted from the proce-
dure notes and subsequently confirmed by independent re-
view of full lateral and anteroposterior angiograms taken be-
fore and after the procedure.
Statistical analysis. Data were analyzed using SAS 9.2
software (SAS Institute Inc, Cary, NC). Descriptive statis-
tics were used to evaluate demographic data. Correlations
between DUS-derived PSVs of the mesenteric arteries and
the degree of angiographic stenosis were analyzed using the
Spearman rank correlation. Prestenting and first, second,
and third poststenting PSVs were compared using the
Friedman test. If the Friedman test was statistically signifi-
cant, then paired PSVs were compared using the Wilcoxon
signed rank test if the distribution was abnormally dis-
tributed and the Student t-test if the data were normally
distributed. Comparisons were deemed significant at
P  .05. bESULTS
During the study period, 24 patients (15 women, 9
en) underwent 31 endovascular mesenteric artery pro-
edures, including initial procedures on native arteries
nd reintervention procedures performed on previously
tented arteries. Patients were a mean age of 79  13
ears (Table I). CMI was the indication for all 31 initial
nd reintervention procedures.
Initial endovascular interventions on the native SMA.
ymptoms were present in 22 of the 23 patients who
nderwent initial stenting of the native SMA. One asymp-
omatic patient underwent elective intervention after an-
iography for an occluded peripheral artery incidentally
dentified occlusion of the SMA and CA with tenuous
ollateral circulation arising from a meandering inferior
esenteric artery.
CTA or MRA was used in 10 patients to confirm native
esenteric occlusive disease, and 13 patients underwent a
US assessment to evaluate the native mesenteric vessels
efore SMA stenting. The mean PSV in the native SMA of
he 13 patients who were evaluated with DUS imaging was
64  130 cm/s (range, 195-645 cm/s), and 12 of these
atients had a PSV 275 cm/s (Fig 1).
At time of endovascular intervention, the mean angio-
raphic stenosis of the native SMA before stenting was
9% 14% (range, 50%-100%) for all 23 patients. Stenosis
f the native SMA was 70% in 19 of these patients, and
oncomitant stenting 70% stenosis was present in the
ative CA in 10 patients. The SMA was stented in 20
atients, and three patients underwent concomitant stent-
ng of the SMA and CA (the degree of angiographic steno-
is was 80% for the three concomitantly stented CAs;
able I). Completion angiography after stenting showed
o residual stenosis in 18 of the SMAs and 20% residual
tenosis in five of the stented SMAs. The residual stenosis of
he three concomitantly stented CAs was 5%.
To determine if the SMA PSVs found using DUS imaging
able I. Native and reintervention revascularization
rocedures and patients
ariable
Mean  SD or No.
(N  24)
ge, years 79  13
ex
Female 15
Male 9
ative mesenteric arteries stented 23
SMA alone 20
SMA  CA 3
eintervention procedures 8
SMA restenting 4
CA restenting 1
SMA angioplasty and CA restenting 1
SMA stent and angioplasty 2
A, Celiac artery; SD, standard deviation; SMA, superior mesenteric artery.efore intervention could predict the degree of angiographic
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November 20121366 Baker et alstenosis found at the time of intervention, an attempt was made
to correlate the twofindings.However, no significant correlation
was identified between preprocedure SMAPSVs foundonDUS
imaging and the degree of angiographic stenosis of the SMA
(Spearman rank P .05).
An initial DUS surveillance after stenting was performed
in 21 patients at a mean follow-up of 0.9  1.5 months
(range, 0-8 months), and the first DUS surveillance in 19
patients was30 days after stenting. Themean PSVmeasure-
ment of stented SMAs at this time in 21 patients was 335 
138 cm/s (range, 130-647 cm/s). The PSV was275 cm/s
in 12 patients (Fig 1). In 17 patients, a poststent DUS surveil-
lance was subsequently performed at a mean of 4.8  2.6
months (range, 1-8 months). The average PSV of the stented
SMAwas 388 157 cm/s (range, 142-611 cm/s), and 14 of
these measurements were275 cm/s. Seven patients under-
went a thirdDUS surveillance at ameanof 14.45.1months
(range, 10-25 months). The mean SMA PSV was 391  97
cm/s (range, 273-502 cm/s), and six patients had an SMA
PSV 275 cm/s. A significant difference existed between
prestenting and the first poststenting mean SMA PSV (Fried-
man test P  .05), but no significant difference existed be-
tween the mean in-stent SMA PSV at each subsequent post-
stenting interval (Fig 2).
Endovascular reinterventions for ISS. Six patients
(5 initially stented at our institution and 1 initially stented
at another hospital) underwent a total of eight repeat
Fig 1. A dot plot shows superior mesenteric artery (SMA) p
SMA.Poststenting surveillancewasperformedat anaverageof
elevated in two patients (dotted lines) and reintervention was
stentingduplexultrasoundassessmentwas converted to anopecatheter-based mesenteric angiographies for suspected ISS sased on clinical findings and elevated in-stent SMA PSVs.
n three patients, stents had been previously placed in the
MA only, and three patients had previously received stents
n both the SMA and CA (Table II).
These eight reinterventionprocedures involved four restent-
ngsof theSMAalone—onecombined restentingof theCAand
ngioplasty of the SMA,one restentingof theCAalone, and two
ngioplasties aloneof thepreviously stentedSMA(Table II).The
ean SMA in-stent PSV for these eight procedures before rein-
erventionwas50574cm/s (range, 415-607cm/s) vs341
45 cm/s in patients who did not undergo reintervention. The
ean angiographic SMA ISS was 53% 25% (range, 0%-80%).
he residual angiographic stenosis in each procedure after rein-
ervention was10%.
Thedecision toperforma reintervention in threeprocedures
asbasedondefinitive returnofprior symptomsandanelevation
f the in-stent SMA PSVs (Table II; Fig 3,A). Another patient
nderwent a reinterventionbecausehehadan in-stentSMAPSV
f611 cm/s alongwith failure to thrive and an inability to regain
eight; however, he did not have typical symptoms of CMI,
ecause he did not regain weight and failed to thrive even after
he reintervention. Four of the procedures, also in the absence of
ymptoms, were performed for an increase in the SMA PSV
dentifiedduring surveillance that started to approach500 cm/s,
f which two cases resulted in almost a doubling of the SMA
n-stent PSV (Fig 3,A).
DUS surveillance in all the patients after reintervention
stolic velocities (PSVs) before and after stenting of the native
1.5months (range,0-8months).The in-stentSMAPSVwas
mmended. One patient (shown as X) who had a pre-SMA
cedurebefore thepoststentingduplexultrasound surveillance.eak sy
0.9
recohowed the in-stent SMA PSV decreased on average to
t
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e
b
f
S
n
v
D
i
5). In
PSV,
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Volume 56, Number 5 Baker et al 1367398  108 cm/s at a mean of 1  1 month, which was
significantly lower than the mean SMA PSV of 505  74
cm/s before reintervention (Student t-test P  .05; Fig 3,
B). All treatments performed for symptomatic ISS resulted
in a postprocedure resolution of symptoms (Table II).
Interestingly, the DUS surveillance in one of the afore-
mentioned patients who had return of symptoms showed
occlusion of the stented CA and elevation of the stented
SMA PSV (Patient 2, Table II). At time of intervention, an
occlusion of the CA stent was found, but angiography
showed the SMA stent was patent. Only the CA stent was
restented, but subsequent DUS imaging measured a decrease
of the SMA PSV to 256 cm/s from 418 cm/s (Fig 4).
Endovascular postprocedure follow-up. No deaths
Fig 2. Mean peak systolic velocities (PSVs) of the super
native SMA during duplex ultrasound (DUS) surveillan
poststent with DUS surveillance performed at 0.9 mon
in-stent SMA PSV at 0.9, 4.8, and 14.4 months (P  .0
Table II. Characteristics of eight reintervention procedure
Patient Prior stent Presymptoms
Pre in-stent
PSV (cm/s)
PSV cha
from pr
DUS (cm
1 (1st) SMA  CA No 493 (SMA) 6
1 (2nd) SMA  CA No 511 (SMA) 9
2 SMA  CA Yes No flow (CA) 548 (C
418 (SMA) 221 (S
3 SMA No 501 (SMA) 21
4 SMA No 607 (SMA) 27
5 SMA No 611 (SMA) 3
6 (1st) SMA  CA Yes 331 (CA) NA
415 (SMA)
6 (2nd) SMA  CA Yes 486 (SMA) 66 (S
CA, Celiac artery; DUS, duplex ultrasound assessment; NA, not applicable;occurred30 days of any of the procedures. Three patients in che native artery stenting cohort developed postprocedure
omplications of the upper extremity artery access site that
equired intervention, comprising one expanding pseudoan-
urysm of the axillary artery and two acute occlusions of the
rachial artery. One patient was converted to an open bypass
or worsening abdominal pain 4 days after stenting of her
MA. Although angiography showed a patent SMA stent, a
ew distal SMA branch occlusion was not amenable to endo-
ascular intervention at time of catheter-based angiography.
ISCUSSION
DUS imaging serves as an effective noninvasive modal-
ty to assess the mesenteric arteries. An SMA PSV of 275
esenteric artery (SMA) before and after stenting of the
significant decrease occurs from prestent to the first
P  .05). No significant difference exists between the
-stent SMA PSVs on average remain 275 cm/s.
rformed for in-stent restenosis
Angiographic
stenosis (%)
Intervention
performed
Post in-stent
PSV (cm/s)
Post
symptoms
70 Angioplasty (SMA) 420 No
70 Restent (SMA) 380 No
98 (CA) 313 (CA) No
0 (SMA) Restent (CA) 256 (SMA)
50 Restent (SMA) 277 No
50 Angioplasty (SMA) 605 No
40 Restent (SMA) 376 No
70 (CA) Restent (CA) 511 (CA) No
80 (SMA) Angioplasty (SMA) 420 (SMA)
60 Restent (SMA) 447 (SMA) No
peak systolic velocity; SMA, superior mesenteric artery.ior m
ce. A
ths (s pe
nge
ior
/s)
4
1
A)
MA)
7
1
4
MA)m/s and CA PSV200 cm/s correlate with a 70% angio-
d
c
s
MA
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November 20121368 Baker et algraphic stenosis of the native vessels, and the high sensitiv-
ity (92%) and negative predictive value (99%) make DUS
imaging a good screening test for mesenteric artery occlu-
Fig 3. A, The change in the in-stent superior mesente
(in-stent SMA surveillance duplex ultrasound imaging) d
seven reintervention procedures (baseline data not availab
changes of the in-stent SMA PSVs after reintervention
resulted in a significant decrease in the average in-stent S
Fig 4. During duplex ultrasound (DUS) surveillance after
celiac artery (CA), occlusion of the CA stent resulted in a c
despite angiographic patency. Reintervention on the CA stentsive disease.1-5 Although these criteria have been well vali- rated in native SMA and CA stenosis, DUS criteria do not
urrently exist for evaluation of the SMA and CA after
tenting for mesenteric occlusive disease. Visceral angiog-
tery (SMA) peak systolic velocity (PSV) from baseline
strates the in-stent SMA PSV guiding reintervention for
r one procedure, shown as a pink dot). B, Shown are the
in-stent stenosis for eight procedures. Reintervention
PSV (P  .05).
ing of both the superior mesenteric artery (SMA) and the
mitant increase of the in-stent SMA peak systolic velocity,
resulted in a subsequent decrease of the in-stent SMA PSV.ric ar
emon
le fo
forstent
oncoaphy functions in confirming the diagnosis of mesenteric
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lance given the risks of angiography. Although other op-
tions, such as CTA and MRA, allow noninvasive radio-
graphic evaluation of stented mesenteric vessels, both
options still have risks from contrast and are associated with a
higher cost. In addition,CTAandMRAdonot provide blood
flow characteristics, which is important information during
graft and stent surveillance. Given the high sensitivity in
screening native vessel mesenteric artery occlusive disease,
DUS imaging would be an ideal surveillance modality to
screen patients with mesenteric artery stents for ISS.
Surveillance of mesenteric stents and bypass graft re-
mains essential in determining potential compromise to the
visceral circulation given the devastating complications of
acute mesenteric artery occlusion. Symptoms often guide
the need for additional radiologic evaluation, but objective
assessment after mesenteric revascularization has been
shown to be more sensitive than assessments of symp-
toms.18 With the advances in endovascular technologies
over the recent decade and a steady rise in use of endovas-
cular techniques as a first-line therapy for CMI, the impor-
tance of regular clinical and radiographic surveillance can-
not be overemphasized.16
Effective surveillance after mesenteric artery stenting is cru-
cial because primary patency rates after endovascular
mesenteric revascularization have ranged from 27% to
92% based on different lengths of follow-up and methods
of assessment. Interestingly, primary assisted patency
rates, which have ranged from 58% to 100%, are typically
greater than primary patency rates with endovascular
stenting.6-8,11-14,25 One of the most recent and largest
endovascular revascularization series to date noted a pri-
mary assisted patency rate of 100% compared with a 44%
primary patency rate at 1 year.25 These data suggest that
early recognition of ISS is important for improving the
overall patency of mesenteric artery stents. Earlier iden-
tification of ISS could then allow for an endovascular
reintervention. In older patients with cardiopulmonary
comorbidities, endovascular interventions and subse-
quent reinterventions may be an overall lower risk option
when compared with the morbidity of open revascular-
ization.15,26,27
Although we were unable to definitively establish a
correlation between the percentage of angiographic steno-
sis of the stented SMA and PSV onDUS imaging, this study
further supports that DUS criteria of 275 cm/s used to
determine high-grade (70%) native SMA stenosis does
not accurately determine ISS. Mitchell et al24 previously
reported the early (45 days) mean PSV in the stented
SMA of 13 patients was 336  45 cm/s, which was
significantly lower than the PSV of the prestent SMA of
450  152 cm/s. Also, Schoch et al25 note that 83% of
patients had increased PSV but 54% remained clinically
asymptomatic. Our findings show that the mean PSVs of
the prestented SMA in 13 patients was 464  130 cm/s,
which significantly decreased after stenting to 335  138
cm/s in 21 patients at early follow-up. In addition to the
PSV of the stented SMAs being on average275 cm/s, the tverage PSV of stented SMAs not reintervened on in our
tudy also did not significantly change over time.
However, the patients who did require restenting or
ngioplasty had an average in-stent SMA PSV of 505 74
m/s (range, 415-611 cm/s), which then significantly
ecreased to 398  108 cm/s after intervention. At the
ime of intervention, the average SMA angiographic ISS
dentified was 53%  25% (range, 0%-80%). The small
umber of patients undergoing reintervention, along with
lack of comparable angiographic data for the patients who
id not undergo reintervention, preclude our ability to
efinitively identify reintervention DUS criteria; however,
hen looking at the individual patients, some common
ndings will likely help guide future studies in determining
US criteria for reintervention (Table II; Fig 3, A).
One common DUS finding among the small number of
atients who underwent reintervention was that an elevated
MA PSV (400 cm/s), combined with the return of symp-
oms, resulted in the identification of patients with ISS who
enefited from reintervention, whereas the finding of relatively
ower SMA in-stent PSV (283 and251 cm/s) in twopersistently
ymptomatic patients in this series helped avoid reintervention
nd eventually led to the identification of nonvascular sources of
heir persistent pain. In addition, patients who did not have
ymptomsbut demonstrated a large increase in the in-stent SMA
SV (almost doubling) compared with prior in-stent SMA PSV
r had an in-stent SMA PSV approaching 500 cm/s correctly
dentifiedSMAISS.Armstrong28 previously showed similar data
nd suggested that patients who required reintervention for ISS
ad an average in-stent SMA PSV of 530 89 cm/s, whereas
atientswhodid not require reintervention had an in-stent SMA
SV of 368 78 cm/s.28
Clinical context, however, remains critical in the use of
US imaging as a surveillance tool. During DUS surveil-
ance of the initial cohort, a few patients had elevated
n-stent PSV but did not undergo reintervention. Two
atients had complete resolution of symptoms, along with
eight gain, despite an in-stent SMA PSV 500 cm/s. In
nother patient, the in-stent SMA PSV more than doubled
uring surveillance, but reintervention was deferred be-
ause the patient was asymptomatic from a mesenteric
cclusive disease standpoint and had stage IV lung cancer.
On the basis of the findings in this study, if DUS imaging is
o be used in surveillance, then an early postprocedure DUS
ssessment of the stented mesenteric arteries should be per-
ormedtoestablishabaseline for futurecomparisons,because the
SV should not be expected to change over time even though
he in-stent SMA PSV will likely be275 cm/s. In addition, a
arge increase from this baseline of the in-stent SMA PSV or a
SV approaching 500 cm/s should be considered suggestive of
SS, especially in the presence of persistent symptoms, but also
ven in the absence of symptoms. In fact, an in-stent SMA PSV
pproaching 500 cm/s immediately after the proceduremay aid
n identifying a residual stenosis that may not have been ade-
uately visualized by angiography, as seen with the use of early
US imagingafteropenperipheral andmesenteric revasculariza-
ion.29,30
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tions of our study are the small sample size and relatively
short follow-up period. A larger sample size would have
potentially allowed us to identify a significant correlation
between in-stent SMA PSV and the degree of angiographic
stenosis of patients requiring reintervention. Also, angio-
graphic data of patients who did not have a reintervention
would have also aided in possibly identifying a correlation
between DUS findings of stented mesenteric vessels. An
attempt was made to compare surveillance DUS imaging
with CTAs, but CTAs performed in follow-up were un-
common. Obtaining mesenteric angiograms to compare
with the respective DUS during longitudinal surveillance
after mesenteric stenting will also likely be a challenge given
the risks of unnecessary angiograms in these patients. As
done for previous validation studies, mesenteric angiogra-
phy will have to be performed concomitantly with other
indicated angiographic procedures. Larger patient cohorts
over longer follow-up periods will be important to better
evaluate the use of DUS surveillance but will also continue
to be a challenge given the low frequency and high mor-
bidity and mortality associated with mesenteric ischemia.
In addition, our study includedpatientswhounderwentCA
intervention in addition to the SMA. The native CAwas stented
concomitantly with the SMA in three patients, and a previously
stentedCAunderwent reintervention in twopatients.Mitchel et
al24 showed that higher pressure gradients across thenative SMA
were associated with a higher-grade stenosis of the CA. The
patient we reported on in Fig 4 is a good case example of this
interdependence between the SMA and CA. How commonly
this phenomenon occurs cannot be determined in this report,
but considerationof the status of theCAandwhether it has been
stentedmay be important to consider when interpreting in-stent
SMA PSV.
CONCLUSIONS
Our data demonstrate that PSVs in successfully stented
SMAs remain higher than the PSV of 275 cm/s used for
diagnosing stenosis of native SMAs. PSVs of the stented
SMAs do not significantly change over time. DUS imaging
should be considered early after a mesenteric artery inter-
vention to establish a baseline with which to compare
future DUS surveillance and to potentially identify signifi-
cant residual stenosis that may benefit from early reinter-
vention. Given the increasing use of endovascular stenting
for mesenteric occlusive disease, additional studies are
needed to more accurately validate DUS criteria for ISS
after mesenteric artery stenting.
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Dr Eugene Zierler (Seattle, Wash). I noticed that in three of
the superior mesenteric artery (SMA) reinterventions, the angio-
graphic severity of restenosis was determined to be 50% or less,
resulting in an average SMA stenosis of 53% prior to reinterven-
tion. Since the average prestenting angiographic SMA stenosis was
79%, how do explain the need for reintervention with these rela-
tively modest stenoses?
Dr Aaron C. Baker. The need for intervention cannot be
made in a vacuum using imaging results primarily, and the clinical
context is essential in deciding to reintervene. These three patients
that had an in-stent restenosis of 50% or less also had concomitant
high-grade stenosis or occlusion of the celiac vessel. Thus, these
patients were less likely to tolerate mesenteric ischemia as a result of
in-stent restenosis or occlusion. In each of these three cases
though, the increased in-stent SMA peak systolic velocity (PSV)
seen on surveillance duplex ultrasound was a critical component to
the clinical decision making, and did lead to correct identification
of in-stent restenosis, but the final decision to reintervene was
made in combination with the overall clinical picture.
Dr Zierler. Second, when the SMA is evaluated by duplex
scanning, it is possible that the flow pattern could be influenced by
the status of the celiac artery and the intervening mesenteric
collateral pathways. This is analogous to the right and left extracra-
nial carotid systems that are connected to a variable extent by the
Circle of Willis. It is well recognized that when there is a unilateral
internal carotid artery stenosis and a contralateral internal carotid
occlusion, flow velocities may be increased on the patent side due
to compensatory collateral flow. This could also occur in the SMA
when the celiac artery is occluded. Of the reinterventions described
in this study, seven involved the SMA and only two involved the
celiac artery. Do you know the status of the celiac arteries in these
cases, and would it be possible to correlate the SMA velocities with
the status of the celiac artery?ressure gradients across the native SMAwere associated with higher-
rade stenosis of the celiac artery (CA). We have a great case example
f this exact phenomenon, which I showed in the figure depicting the
n-stent PSV changes that resulted in reintervention (Fig 4). This
atient had both CA and SMA stents and then had in-stent occlusion
f only the CA. What we can see is the SMA in-stent PSV increased
ith occlusion of the CA, but the SMA stent was completely patent.
fter successful restenting of the occludedCA stent, the in-stent SMA
SV subsequently decreased.While we can clearly see the interdepen-
ence between the CA and SMA in this case example, it was not
eadily apparent in other cases, and we did not specifically try to
orrelate the in-stent SMAvelocitieswith status of theCA.Aswewere
nable to correlate in-stent SMA and CA with angiographic stenosis,
would speculate that the correlation will be difficult to identify
iven our small number of patients in the reintervention cohort.
dditionally, we showed in the group of patients undergoing
nitial stenting of the SMA or CA that the CA PSV did not
ignificantly change from pre- to poststenting of either the CA
r the SMA. Similarly no significant change occurs between the
n-stent CA PSV pre- and postreintervention.
Dr Zierler. And finally, the flow pattern in the proximal SMA
an also be affected by a replaced right hepatic artery, which is
resent in 15% or more of the population. This is one recognized
ause of increased velocities in a normal native SMA. Do you recall
oting any replaced right hepatic arteries in your case series?
Dr Baker. A replaced right hepatic artery could have certainly
ontributed to increased in-stent SMA PSV, but we did not specifi-
ally evaluate its presence in our patients. Even if we were to investi-
ate this further, it is possible the stored images available for our
eview may not have captured the replaced right hepatic artery.
ertainly, any prospective study should consider the effect of a re-
laced right hepatic artery as well as evaluating the relationship be-
ween the CA and SMA, as we discussed with the previous question.INVITED COMMENTARYGustavo S. Oderich, MD, Rochester, Minn
Mesenteric stents have been plagued by high rates of restenosis
(20%-66%) and reintervention.1 Although most reinterventions are
indicated for chronic symptoms, a minority of patients can present
with acute stent thrombosis andbowel ischemia.1 In a recent survey ofesenteric ischemia, acute mesenteric ischemia was the fourth most
ommon cause of death, occurring in7%of patients after dismissal.2
herefore, patients treated by mesenteric stents should be followed
ith clinical examination and duplex ultrasound surveillance to detect
ecurrent symptoms and high-grade restenosis.
